Hans G. Nilsson
Direktor/Vorstandsmitglied bei PharmNovo AB
Aktive Positionen von Hans G. Nilsson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
PharmNovo AB
 PharmNovo AB Miscellaneous Commercial ServicesCommercial Services PharmNovo AB operates as an biotechnology company. It cures diseases related to pain management such as anxiety, depression, chronic pain, neuroprotection, and osteoarthritis. The company was founded by Bengt von Mentzer in 2008 and is headquartered in Lund, Sweden. | Direktor/Vorstandsmitglied | 01.01.2018 | - |
Karriereverlauf von Hans G. Nilsson
Ehemalige bekannte Positionen von Hans G. Nilsson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
AstraZeneca R&D Boston, Inc.
 AstraZeneca R&D Boston, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca R&D Boston, Inc. develops, manufactures and markets prescription pharmaceutical drugs. The company is headquartered in Cambridge, MA. | Präsident | - | - |
Statistik
International
| Vereinigte Staaten | 2 |
| Schweden | 2 |
Operativ
| President | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
AstraZeneca R&D Boston, Inc.
AstraZeneca R&D Boston, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca R&D Boston, Inc. develops, manufactures and markets prescription pharmaceutical drugs. The company is headquartered in Cambridge, MA. | Health Technology |
PharmNovo AB
PharmNovo AB Miscellaneous Commercial ServicesCommercial Services PharmNovo AB operates as an biotechnology company. It cures diseases related to pain management such as anxiety, depression, chronic pain, neuroprotection, and osteoarthritis. The company was founded by Bengt von Mentzer in 2008 and is headquartered in Lund, Sweden. | Commercial Services |
- Börse
- Insiders
- Hans G. Nilsson
- Erfahrung
